The RSA Group, a leading Life Sciences executive search firm, is pleased to announce the launch of its debut podcast “RSA Talent Talks: Cell & Gene Therapy”, now available for download here. The podcast delves into the Cell & Gene Therapy sector, sharing insights from The RSA Groups latest Talent Equity® Report and offering unique perspectives from two experts in this field – Nick Stephens, Executive Chairman, RSA, and Mark Johnson, Partner, RSA.

C&G companies are opening the door to a paradigm shift in medicine, rapidly developing exciting new therapeutics to deliver meaningful results for patients. However, C&G companies face unique challenges. They are subject to short time-frames, putting company leaders under high pressure from day one and creating the need for an alternative, faster growth strategy dependent on people and money. Management teams need to be built faster and be more broadly-based than in purely R&D focused drug discovery enterprises.

During this podcast, Nick and Mark discuss the profiles of leaders at the heart of these companies, and the ways in which they assemble winning teams that evolve and flex over time according to the funding available and pipeline needs.

To keep up to date with latest reports and industry insights check out RSA’s LinkedIn Page and Twitter Page, and stay tuned for the next ‘RSA Talent Talks’ podcast.

Share this: